The Brighterside of News on MSN9d
Life changing hypertension medication also extends life expectancyScientists have identified a widely prescribed hypertension drug as a potential key to extending lifespan and slowing aging.
The Tryvio REMS program was established due to the risk of birth defects associated with the ERA drug class. Prior to dispensing Tryvio, patients of reproductive potential were required to report a ...
GlobalData on MSN11d
Mineralys’s stock soars as hypertension pill scores in two pivotal trialsMineralys Therapeutics’s oral hypertension therapy, lorundrostat, has met the primary endpoint in two pivotal studies, ...
Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in ...
Systolic blood pressure kept under 130 reduces the risk of heart-related death by about 26% among people 80 or older, ...
Lorundrostat demonstrated strong efficacy and safety in the pivotal Phase 3 Launch-HTN and Phase 2 Advance-HTN trials. These ...
A recent article suggests that increased efforts by clinicians to promote healthy sleep habits may prevent hypertension in ...
HOLDINGS has completed a draw on its Equity Line of Credit to support the commercial launch of Arbli Oral Suspension, while ...
Primary endpoints of both Advance-HTN and Launch-HTN studies, using lorundrostat to treat patients with hypertension were met ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback